CollaGenex Will Launch Oracea In July With Specialty Sales Force
This article was originally published in The Pink Sheet Daily
Executive Summary
Oracea cleared FDA as the first orally administered, systemically delivered drug to treat rosacea.
You may also be interested in...
Galderma Acquires CollaGenex For $420 Million
Swiss firm fattens dermatological portfolio with acquisition.
Galderma Acquires CollaGenex For $420 Million
Swiss firm fattens dermatological portfolio with acquisition.
CollaGenex, QuatRx Agree To Develop Topical Psoriasis Treatment
CollaGenex tells “The Pink Sheet” DAILY it expects to launch becocalcidiol for treatment of psoriasis between late 2010 and early 2012.